Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuannan, Sun"'
Autor:
Yaping Deng, Xue Han, Zheng Yao, Yuannan Sun, Jiawen Yu, Jian Cai, Guofei Ren, Guojun Jiang, Feng Han
Publikováno v:
Cellular Physiology and Biochemistry, Vol 42, Iss 6, Pp 2255-2266 (2017)
Background: Impaired wound healing is a common complication of diabetes and is the leading cause of lower extremity amputation. Treatment with fenofibrate, a peroxisome proliferators–activated receptor α (PPARα) agonist, was associated with a low
Externí odkaz:
https://doaj.org/article/7c13e53c3aa4452bba551ab197a918f7
Publikováno v:
Molecular Medicine Reports
Wound healing impairment is increasingly recognized to be a consequence of hyperglycemia-induced dysfunction of endothelial precursor cells (EPCs) in type 2 diabetes mellitus (T2DM). Metformin exhibits potential for the improvement of endothelial fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fc8c160e9db1ebe08547bac0401c85f
https://doi.org/10.3892/mmr.2017.7707
https://doi.org/10.3892/mmr.2017.7707
Autor:
Yuannan Sun, Jianjun Zhu, Guo-Fei Ren, Xue Han, Jian Cai, Guo-Jun Jiang, Ya-Ping Deng, Jia-Wen Yu
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2017 (2017)
Refractory wound is a dreaded complication of diabetes and is highly correlated with EPC dysfunction caused by hyperglycemia. Acarbose is a widely used oral glucose-lowering drug exclusively for T2DM. Previous studies have suggested the beneficial ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f5084964999550f1eae883b65d3cac
Autor:
Xue, Han, Yaping, Deng, Jiawen, Yu, Yuannan, Sun, Guofei, Ren, Jian, Cai, Jianjun, Zhu, Guojun, Jiang
Publikováno v:
Oxidative Medicine and Cellular Longevity
Refractory wound is a dreaded complication of diabetes and is highly correlated with EPC dysfunction caused by hyperglycemia. Acarbose is a widely used oral glucose-lowering drug exclusively for T2DM. Previous studies have suggested the beneficial ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::53c577a8e8df8a85268f5b4a0f5ddac8
https://pubmed.ncbi.nlm.nih.gov/28373902
https://pubmed.ncbi.nlm.nih.gov/28373902
Autor:
Jia-Wen Yu, Yu-Long Tao, Ya-Ping Deng, Guo-Fei Ren, Guo-Jun Jiang, Jian Cai, Xue Han, Yuannan Sun
Publikováno v:
PeerJ
PeerJ, Vol 5, p e3155 (2017)
PeerJ, Vol 5, p e3155 (2017)
Background & AimsMetformin is currently the most widely used first-line hypoglycemic agent for diabetes mellitus. Besides glucose-lowering action, there is increasingly interest in the potential anti-inflammatory action of this drug. In the present s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::459f7d39eda05b27848d299c54c113cd
https://doi.org/10.7717/peerj.3155
https://doi.org/10.7717/peerj.3155
Publikováno v:
Molecular Medicine Reports; Dec2017, Vol. 16 Issue 6, p8691-8698, 8p